Spire Healthcare Group (LON:SPI) Rating Reiterated by Liberum Capital
Spire Healthcare Group (LON:SPI)‘s stock had its “hold” rating reaffirmed by investment analysts at Liberum Capital in a research report issued to clients and investors on Wednesday, ThisIsMoney.Co.Uk reports.
SPI has been the subject of several other research reports. Jefferies Financial Group cut Spire Healthcare Group to an “underperform” rating and raised their target price for the stock from GBX 106 ($1.39) to GBX 113 ($1.49) in a research note on Tuesday, January 21st. Barclays reaffirmed an “underweight” rating on shares of Spire Healthcare Group in a research note on Tuesday, January 7th. Peel Hunt reaffirmed an “add” rating on shares of Spire Healthcare Group in a research note on Friday, March 13th. UBS Group raised their target price on Spire Healthcare Group from GBX 117 ($1.54) to GBX 121 ($1.59) and gave the stock a “neutral” rating in a research note on Tuesday, February 11th. Finally, Peel Hunt reaffirmed an “add” rating and set a GBX 155 ($2.04) target price on shares of Spire Healthcare Group in a research note on Wednesday, January 8th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the stock. Spire Healthcare Group presently has a consensus rating of “Hold” and an average target price of GBX 130.44 ($1.72).
LON SPI traded up GBX 0.05 ($0.00) during trading hours on Wednesday, hitting GBX 52.60 ($0.69). 5,252,477 shares of the company’s stock were exchanged, compared to its average volume of 1,770,000. The stock has a 50-day simple moving average of GBX 114.54 and a 200 day simple moving average of GBX 121.36. Spire Healthcare Group has a 1-year low of GBX 61.25 ($0.81) and a 1-year high of GBX 145 ($1.91). The firm has a market cap of $210.97 million and a price-to-earnings ratio of 29.22. The company has a current ratio of 1.03, a quick ratio of 0.77 and a debt-to-equity ratio of 124.33.
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Read More: What is the CAC 40 Index
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.